Early safety after TAVR according to VARC-3 criteria: incidence, predictors, and clinical impact.
Gonzálvez-García A, Cepas-Guillén P, Ternacle J, Urena M, Alperi A, Cheema A, Veiga-Fernández G, Nombela-Franco L, Vilalta V, Esposito G, Campelo-Parada F, Idolfi C, Trigo MD, Muñoz-García A, Maneiro N, Asmarats L, Regueiro A, Val DD, Serra V, Auffret V, Jonveaux M, Bonnet G, Mesnier J, Gaspard S, Avanzas P, Rezaei E, Fradejas-Sastre V, Tirado-Conte G, Fernández-Nofrerías E, Franzone A, Guitteny T, Sorrentino S, Oteo JF, Diez-Delhoyo F, Gutiérrez-Alonso L, Vidal P, Alfonso F, Monastyrski A, Nolf M, Pelletier-Beaumont E, Avvedimento M, Rodés-Cabau J.
Gonzálvez-García A, et al. Among authors: cheema a.
Rev Esp Cardiol (Engl Ed). 2024 Dec 23:S1885-5857(24)00363-3. doi: 10.1016/j.rec.2024.12.005. Online ahead of print.
Rev Esp Cardiol (Engl Ed). 2024.
PMID: 39722415
English, Spanish.